Merck KGaA (MKGAF) News Today $138.05 +0.05 (+0.04%) As of 03/28/2025 02:57 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesShort InterestBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Zebra Technologies, Merck KGaA enter safety and traceability solutions pactMarch 29 at 3:59 AM | markets.businessinsider.comMerck KGaA (OTCMKTS:MKGAF) Stock Crosses Below 50 Day Moving Average - Should You Sell?Merck KGaA (OTCMKTS:MKGAF) Stock Price Passes Below 50-Day Moving Average - Here's WhyMarch 25, 2025 | marketbeat.comMerck KGaA (OTCMKTS:MKGAF) Sees Significant Growth in Short InterestMerck KGaA (OTCMKTS:MKGAF - Get Free Report) saw a significant increase in short interest in the month of February. As of February 28th, there was short interest totalling 555,200 shares, an increase of 27.9% from the February 13th total of 434,000 shares. Approximately 0.4% of the shares of the company are short sold. Based on an average daily trading volume, of 600 shares, the days-to-cover ratio is currently 925.3 days.March 18, 2025 | marketbeat.comMerck opens $1 billion addition in north Durham to boost production of popular vaccineMarch 11, 2025 | msn.comMerck KGaA (OTCMKTS:MKGAF) Shares Cross Below 50-Day Moving Average - Time to Sell?Merck KGaA (OTCMKTS:MKGAF) Stock Price Passes Below 50 Day Moving Average - Here's What HappenedMarch 11, 2025 | marketbeat.comMerck KGaA (MKGAF) Q4 2024 Earnings Call Highlights: Strong Organic Growth and Strategic ...March 7, 2025 | finance.yahoo.comMerck KGaA sees forex-adjusted earnings growth of up to 8% this yearMarch 6, 2025 | reuters.comMerck KGaA (OTCMKTS:MKGAF) Sees Large Increase in Short InterestMerck KGaA (OTCMKTS:MKGAF - Get Free Report) saw a large growth in short interest in February. As of February 15th, there was short interest totalling 434,000 shares, a growth of 63.0% from the January 31st total of 266,200 shares. Based on an average trading volume of 300 shares, the days-to-cover ratio is presently 1,446.7 days.March 2, 2025 | marketbeat.comSpringWorks Therapeutics jumps after results, conference call cancellationFebruary 20, 2025 | msn.comMorgan Stanley cuts Merck KGaA stock rating, target to EUR160February 12, 2025 | msn.comSpringWorks gets FDA approval for mirdametinibFebruary 11, 2025 | msn.comMerck KGaA (OTCMKTS:MKGAF) Sets New 1-Year Low - Should You Sell?Merck KGaA (OTCMKTS:MKGAF) Hits New 1-Year Low - Time to Sell?February 10, 2025 | marketbeat.comSpringWorks jumps as Merck KGaA reportedly in talks to acquire companyFebruary 10, 2025 | markets.businessinsider.comMerck KGaA in advanced talks to acquire SpringWorks Therapeutics, Reuters saysFebruary 10, 2025 | markets.businessinsider.comExclusive: Germany's Merck KGaA in talks to buy US cancer biotech firm Springworks, sources sayFebruary 10, 2025 | reuters.comMerck Q4 2024 Earnings Preview: Headwinds ahead, but familiar strengths to persistFebruary 3, 2025 | seekingalpha.comMerck announces $10B share repurchase authorizationJanuary 28, 2025 | markets.businessinsider.comMerck KGaA says high asset prices call for prudent M&A approachJanuary 23, 2025 | reuters.comMerck KGaA (OTCMKTS:MKGAF) Stock Crosses Below 50 Day Moving Average - Time to Sell?Merck KGaA (OTCMKTS:MKGAF) Stock Price Passes Below 50 Day Moving Average - What's Next?January 21, 2025 | marketbeat.comKepler Capital Keeps Their Buy Rating on Merck KGaA (0O14)January 15, 2025 | markets.businessinsider.comMerck KGaA (OTCMKTS:MKGAF) Shares Pass Below 50 Day Moving Average - What's Next?Merck KGaA (OTCMKTS:MKGAF) Stock Price Passes Below 50-Day Moving Average - Time to Sell?January 11, 2025 | marketbeat.comMerck KGaA (OTCMKTS:MKGAF) Stock Price Crosses Below Fifty Day Moving Average - Here's What HappenedMerck KGaA (OTCMKTS:MKGAF) Stock Crosses Below 50 Day Moving Average - Here's WhyJanuary 3, 2025 | marketbeat.comMerck KGaA (OTCMKTS:MKGAF) Reaches New 12-Month Low - Here's WhyMerck KGaA (OTCMKTS:MKGAF) Sets New 52-Week Low - What's Next?December 26, 2024 | marketbeat.comMerck KGaA (OTCMKTS:MKGAF) Hits New 1-Year Low - Should You Sell?Merck KGaA (OTCMKTS:MKGAF) Sets New 12-Month Low - Here's WhyDecember 19, 2024 | marketbeat.comMerck posts mixed late-stage trial results for HIV treatmentDecember 19, 2024 | msn.comMerck enters obesity drug race in pact with Chinese pharma HansohDecember 18, 2024 | seekingalpha.comStrong Fundamentals And Weight Loss Entry Make Merck (MRK) A BuyDecember 18, 2024 | msn.comMerck KGaA (OTCMKTS:MKGAF) Trading Up 0.8% - Here's What HappenedMerck KGaA (OTCMKTS:MKGAF) Stock Price Up 0.8% - Here's WhyDecember 13, 2024 | marketbeat.comMerck reinstated with a Buy at BofADecember 10, 2024 | markets.businessinsider.comShort Interest in Merck KGaA (OTCMKTS:MKGAF) Grows By 19.7%Merck KGaA (OTCMKTS:MKGAF - Get Free Report) saw a significant growth in short interest in October. As of October 31st, there was short interest totalling 284,600 shares, a growth of 19.7% from the October 15th total of 237,800 shares. Based on an average daily volume of 300 shares, the days-to-cover ratio is currently 948.7 days.November 17, 2024 | marketbeat.comMerck KGaA (MKGAF) Q3 2024 Earnings Call Highlights: Strong Organic Growth Amid Currency HeadwindsNovember 15, 2024 | uk.finance.yahoo.comMerck KGaA (MKGAF) Q3 2024 Earnings Call TranscriptNovember 14, 2024 | seekingalpha.comMerck KGaA Earnings Growth Beats ExpectationsNovember 14, 2024 | wsj.comMerck KGaA: Phase III Trial Of Pimicotinib In Tenosynovial Giant Cell Tumor Meets Primary EndpointNovember 13, 2024 | markets.businessinsider.comMerck narrows outlook; Keytruda drives Q3 beat despite Gardasil impactOctober 31, 2024 | seekingalpha.comMerck KGaA (OTCMKTS:MKGAF) Short Interest UpdateMerck KGaA (OTCMKTS:MKGAF - Get Free Report) was the target of a large decrease in short interest in September. As of September 30th, there was short interest totalling 193,700 shares, a decrease of 23.5% from the September 15th total of 253,200 shares. Based on an average trading volume of 200 shares, the short-interest ratio is currently 968.5 days.October 15, 2024 | marketbeat.comMerck KGaA (0O14) Receives a Buy from JefferiesOctober 4, 2024 | markets.businessinsider.comMerck: Favezelimab/Keytruda Combo Study Misses Goal in Colorectal CancerSeptember 25, 2024 | marketwatch.comMerck Says Phase 3 KEYFORM-007 Study Did Not Meet Primary Goal Of Overall SurvivalSeptember 25, 2024 | markets.businessinsider.comMerck fails in late-stage trial for Keytruda combo in colon cancerSeptember 25, 2024 | seekingalpha.comMerck says trial of combination treatment for colon cancer failed to meet main goalSeptember 25, 2024 | msn.comMerck KGaA (OTCMKTS:MKGAF) Lifted to Strong-Buy at The Goldman Sachs GroupThe Goldman Sachs Group upgraded Merck KGaA to a "strong-buy" rating in a report on Thursday.September 20, 2024 | marketbeat.comWhy Did Merck Stock Rise 65%?September 6, 2024 | forbes.comMerck KGaA (OTCMKTS:MKGAF) Hits New 12-Month High at $196.92Merck KGaA (OTCMKTS:MKGAF) Reaches New 1-Year High at $196.92August 28, 2024 | marketbeat.comMerck wins EU nod for rare lung disease drug WinrevairAugust 26, 2024 | seekingalpha.comMerck KGaA (OTCMKTS:MKGAF) Shares Pass Above 50-Day Moving Average of $174.28Merck KGaA (OTCMKTS:MKGAF) Share Price Crosses Above 50 Day Moving Average of $174.28August 16, 2024 | marketbeat.comMerck: Buy This Bargain Before It's GoneAugust 12, 2024 | seekingalpha.comMerck KGaA (OTCMKTS:MKGAF) Share Price Passes Below Fifty Day Moving Average of $174.29Merck KGaA (OTCMKTS:MKGAF) Shares Cross Below Fifty Day Moving Average of $174.29August 6, 2024 | marketbeat.comMerck KGaA Profit Falls After Cancer Drug Candidate DroppedAugust 1, 2024 | morningstar.comMerck reports earlier-than-expected improvement in semiconductor marketAugust 1, 2024 | msn.com Remove Ads Get Merck KGaA News Delivered to You Automatically Sign up to receive the latest news and ratings for MKGAF and its competitors with MarketBeat's FREE daily newsletter. Email Address MKGAF Media Mentions By Week MKGAF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MKGAF News Sentiment▼0.360.82▲Average Medical News Sentiment MKGAF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MKGAF Articles This Week▼21▲MKGAF Articles Average Week Remove Ads Get Merck KGaA News Delivered to You Automatically Sign up to receive the latest news and ratings for MKGAF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Zoetis News Regeneron Pharmaceuticals News Takeda Pharmaceutical News Daiichi Sankyo News Alnylam Pharmaceuticals News UCB News UCB News Bayer Aktiengesellschaft News Beigene News Royalty Pharma News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:MKGAF) was last updated on 3/31/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Merck KGaA Please log in to your account or sign up in order to add this asset to your watchlist. Share Merck KGaA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
